Therapy Areas: Autoimmune
Immunovia agrees on early termination of lung cancer collaboration with global pharmaceutical company
8 April 2020 - Immunovia AB (publ) reported on Tuesday that the lung cancer collaboration with a global pharmaceutical company is void and cancelled.However, Immunovia's own early detection progr...
The international iReceptor Plus consortium to launch technology tools and infrastructure to aid COVID-19 treatment
7 April 2020 - The international iReceptor Plus consortium, an international project co-funded by the EU and the Canadian government, is launching the technology tools and infrastructure developed wit...
Immunovia updates on actions taken during COVID-19 pandemic
2 April 2020 - Immunovia AB (STO:IMMNOV), a diagnostic company developing and commercialising highly accurate blood tests for the early detection of cancer and autoimmune diseases based on its proprie...
Can-Fite Implements Interim Analysis for its Phase III Psoriasis Trial with Data Expected 4Q20
1 April 2020 - - Israel-based biotechnology company Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) is implementing an interim analysis of the Phase III Comfort trial designed to evaluate t...
Innoplexus uses AI discovery platform to find potential combinations of prior approved drugs for COVID-19
27 March 2020 - AI-based drug discovery and development company Innoplexus AG on Thursday provided an update of the first results from its artificial intelligence enabled search for a COVID-19 antivir...
Innoplexus reveals certain first results in artificial intelligence enabled search for COVID-19 treatment
27 March 2020 - Innoplexus AG, a global AI-based platform for drug discovery and development, has revealed certain first results in its artificial intelligence enabled search for a COVID-19 antiviral ...